Home › Funds › Almitas Capital LLC › ANTX
Almitas Capital LLC position in ANTX
AN2 THERAPEUTICS INC · Health Care
Almitas Capital LLC reported holding 1,469,129 shares of ANTX (AN2 THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$7.1M, representing 1.70% of its reported portfolio and ranking #12 among its reported holdings. Almitas Capital LLC has disclosed ANTX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Almitas Capital LLC's ANTX position evolved
Almitas Capital LLC first disclosed a stake in ANTX in Q4 2024 at 1,313,111 shares (US$1.8M). The position peaked in Q2 2026 at 1,469,129 shares, worth US$7.1M. Across 7 filings, Almitas Capital LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 1,469,129 shares valued at US$7.1M — a reduction of -10,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 1.31M | $1.81M | New |
| Q1 2025 | 1.31M | $1.79M | Hold |
| Q2 2025 | 1.43M | $1.51M | Add |
| Q3 2025 | 1.43M | $1.81M | Hold |
| Q4 2025 | 1.48M | $1.69M | Add |
| Q1 2026 | 1.48M | $5.06M | Hold |
| Q2 2026 | 1.47M | $7.11M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANTX and 13F data
ANTX (AN2 THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in ANTX — the largest reported positions include Vivo Capital, LLC (US$15.3M), Commodore Capital LP (US$14.2M), Spruce Street Capital LP (US$8.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANTX
- Vivo Capital, LLC 3.15M sh · $15.26M · Q2 2026
- Commodore Capital LP 2.93M sh · $14.20M · Q2 2026
- Spruce Street Capital LP 1.66M sh · $8.04M · Q2 2026
- Boxer Capital Management, LLC 749.03K sh · $3.63M · Q2 2026
- Stonepine Capital Management, LLC 551.69K sh · $2.67M · Q2 2026
- Sio Capital Management, LLC 529.93K sh · $2.56M · Q2 2026
- Ally Bridge Group (NY) LLC 526.32K sh · $2.55M · Q2 2026
- Prosight Management, LP 474.64K sh · $2.30M · Q2 2026
- Aldebaran Capital, LLC 367.44K sh · $1.78M · Q2 2026
- Velan Capital Investment Management LP 40.00K sh · $193.60K · Q2 2026
More on Almitas Capital LLC
FAQ
How long has Almitas Capital LLC held ANTX?
Almitas Capital LLC has disclosed ANTX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is Almitas Capital LLC's current position in ANTX?
As of Q2 2026, Almitas Capital LLC holds 1.47M shares of ANTX (AN2 THERAPEUTICS INC), valued at $7.11M, representing 1.70% of its reported portfolio and ranking #12.
Has Almitas Capital LLC been buying or selling ANTX?
In the latest 13F filing (Q2 2026), Almitas Capital LLC reduced its position in ANTX. The position peaked in Q2 2026 at 1.47M shares.
Which other funds hold ANTX?
Other major institutional holders of ANTX include Vivo Capital, LLC, Commodore Capital LP, Spruce Street Capital LP, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.